Chen P - Search Results

1

Circulating TP73-AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non-small cell lung cancer.

Yuan RX, Dai CH, Chen P, Lv MJ, Shu Y, Wang ZP, Xu YP, Li J. Yuan RX, et al. Among authors: chen p. Cancer Med. 2023 Jan;12(2):1655-1672. doi: 10.1002/cam4.5013. Epub 2022 Jul 24. Cancer Med. 2023. PMID: 35871358 Free PMC article.

2

Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer.

Jiang HG, Li J, Shi SB, Chen P, Ge LP, Jiang Q, Tang XP. Jiang HG, et al. Among authors: chen p. Med Oncol. 2014 Jul;31(7):22. doi: 10.1007/s12032-014-0022-8. Epub 2014 May 27. Med Oncol. 2014. PMID: 24861920

3

Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.

Chen P, Li J, Jiang HG, Lan T, Chen YC. Chen P, et al. Among authors: chen yc. Tumour Biol. 2015 May;36(5):3591-9. doi: 10.1007/s13277-014-2996-4. Epub 2014 Dec 27. Tumour Biol. 2015. PMID: 25542235

4

RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.

Dai CH, Li J, Chen P, Jiang HG, Wu M, Chen YC. Dai CH, et al. Among authors: chen p, chen yc. J Biomed Sci. 2015 Sep 18;22(1):77. doi: 10.1186/s12929-015-0185-4. J Biomed Sci. 2015. PMID: 26385482 Free PMC article.

5

The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.

Chen P, Li J, Chen YC, Qian H, Chen YJ, Su JY, Wu M, Lan T. Chen P, et al. Among authors: chen yj, chen yc. Cell Oncol (Dordr). 2016 Dec;39(6):511-522. doi: 10.1007/s13402-016-0291-7. Epub 2016 Jul 29. Cell Oncol (Dordr). 2016. PMID: 27473273

6

Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.

Dai CH, Chen P, Li J, Lan T, Chen YC, Qian H, Chen K, Li MY. Dai CH, et al. Among authors: chen k, chen p, chen yc. Oncotarget. 2016 Oct 4;7(40):65157-65170. doi: 10.18632/oncotarget.11214. Oncotarget. 2016. PMID: 27533083 Free PMC article.

7

Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.

Jiang HG, Chen P, Su JY, Wu M, Qian H, Wang Y, Li J. Jiang HG, et al. Among authors: chen p. J Cell Physiol. 2017 Dec;232(12):3433-3443. doi: 10.1002/jcp.25792. Epub 2017 Feb 13. J Cell Physiol. 2017. PMID: 28075014

8

Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.

Dai CH, Wang Y, Chen P, Jiang Q, Lan T, Li MY, Su JY, Wu Y, Li J. Dai CH, et al. Among authors: chen p. Sci Rep. 2017 Nov 8;7(1):15031. doi: 10.1038/s41598-017-15172-4. Sci Rep. 2017. PMID: 29118324 Free PMC article.

9

Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.

Li XQ, Ren J, Chen P, Chen YJ, Wu M, Wu Y, Chen K, Li J. Li XQ, et al. Among authors: chen yj, chen k, chen p. Acta Pharmacol Sin. 2018 Aug;39(8):1359-1372. doi: 10.1038/aps.2017.187. Epub 2018 May 31. Acta Pharmacol Sin. 2018. PMID: 29849128 Free PMC article.

10

Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.

Chen P, Wu JN, Shu Y, Jiang HG, Zhao XH, Qian H, Chen K, Lan T, Chen CG, Li J. Chen P, et al. Among authors: chen k, chen cg. Clin Sci (Lond). 2018 Jul 9;132(13):1417-1433. doi: 10.1042/CS20180010. Print 2018 Jul 16. Clin Sci (Lond). 2018. PMID: 29853661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,274 results

Search Page

Filters